Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder.

Ballard ED, Vande Voort JL, Bernert RA, Luckenbaugh DA, Richards EM, Niciu MJ, Furey ML, Duncan WC Jr, Zarate CA Jr.

J Clin Psychiatry. 2016 Jun;77(6):825-31. doi: 10.4088/JCP.15m09943.

PMID:
27337418
2.

Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study.

Ballard ED, Vande Voort JL, Luckenbaugh DA, Machado-Vieira R, Tohen M, Zarate CA.

Bipolar Disord. 2016 Jun;18(4):363-72. doi: 10.1111/bdi.12397. Epub 2016 May 27.

PMID:
27233466
3.

The role of adipokines in the rapid antidepressant effects of ketamine.

Machado-Vieira R, Gold PW, Luckenbaugh DA, Ballard ED, Richards EM, Henter ID, De Sousa RT, Niciu MJ, Yuan P, Zarate CA Jr.

Mol Psychiatry. 2016 Apr 5. doi: 10.1038/mp.2016.36. [Epub ahead of print]

PMID:
27046644
4.

Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.

Nugent AC, Iadarola ND, Miller FG, Luckenbaugh DA, Zarate CA Jr.

Lancet Psychiatry. 2016 May;3(5):436-42. doi: 10.1016/S2215-0366(16)00006-7. Epub 2016 Mar 10.

PMID:
26971192
5.

An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.

Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA Jr.

J Affect Disord. 2016 Apr;194:115-9. doi: 10.1016/j.jad.2016.01.009. Epub 2016 Jan 19.

PMID:
26807672
6.

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

Richards EM, Mathews DC, Luckenbaugh DA, Ionescu DF, Machado-Vieira R, Niciu MJ, Duncan WC, Nolan NM, Franco-Chaves JA, Hudzik T, Maciag C, Li S, Cross A, Smith MA, Zarate CA Jr.

Psychopharmacology (Berl). 2016 Mar;233(6):1119-30. doi: 10.1007/s00213-015-4195-4. Epub 2016 Jan 4.

PMID:
26728893
7.

Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders.

Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA Jr.

J Psychiatr Res. 2015 Sep;68:99-105. doi: 10.1016/j.jpsychires.2015.06.012. Epub 2015 Jun 24.

PMID:
26228407
8.

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsché NE, Ameli R, Niciu MJ, Vande Voort JL, Zarate CA Jr.

J Psychiatr Res. 2015 Sep;68:68-73. doi: 10.1016/j.jpsychires.2015.06.003. Epub 2015 Jun 16.

PMID:
26228403
9.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.

Xu AJ, Niciu MJ, Lundin NB, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Machado-Vieira R, Zarate CA Jr.

Neural Plast. 2015;2015:858251. doi: 10.1155/2015/858251. Epub 2015 Jun 7.

10.

Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation.

Lally N, An L, Banerjee D, Niciu MJ, Luckenbaugh DA, Richards EM, Roiser JP, Shen J, Zarate CA Jr, Nugent AC.

J Magn Reson Imaging. 2016 Jan;43(1):88-98. doi: 10.1002/jmri.24970. Epub 2015 Jun 7.

PMID:
26059603
11.

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.

Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA Jr.

J Psychopharmacol. 2015 May;29(5):596-607. doi: 10.1177/0269881114568041. Epub 2015 Feb 17.

PMID:
25691504
12.

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography.

Ionescu DF, Nugent AC, Luckenbaugh DA, Niciu MJ, Richards EM, Zarate CA, Furey ML.

Acta Neuropsychiatr. 2015 Jun;27(3):143-52. doi: 10.1017/neu.2014.46. Epub 2015 Jan 20.

PMID:
25600154
13.

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.

Luckenbaugh DA, Ameli R, Brutsche NE, Zarate CA Jr.

J Psychiatr Res. 2015 Feb;61:40-5. doi: 10.1016/j.jpsychires.2014.12.015. Epub 2014 Dec 27.

14.

Neural correlates of suicidal ideation and its reduction in depression.

Ballard ED, Lally N, Nugent AC, Furey ML, Luckenbaugh DA, Zarate CA Jr.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu069. doi: 10.1093/ijnp/pyu069.

15.

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Furey ML, Zarate CA Jr.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu039. doi: 10.1093/ijnp/pyu039.

16.

Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression.

Ortiz R, Niciu MJ, Lukkahati N, Saligan LN, Nugent AC, Luckenbaugh DA, Machado-Vieira R, Zarate CA Jr.

J Affect Disord. 2015 Feb 1;172:307-11. doi: 10.1016/j.jad.2014.09.015. Epub 2014 Oct 16.

17.

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Zarate CA Jr.

Bipolar Disord. 2015 Jun;17(4):438-43. doi: 10.1111/bdi.12277. Epub 2014 Nov 14.

18.

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.

Lally N, Nugent AC, Luckenbaugh DA, Ameli R, Roiser JP, Zarate CA.

Transl Psychiatry. 2014 Oct 14;4:e469. doi: 10.1038/tp.2014.105.

19.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA Jr.

J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.

PMID:
25295436
20.

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, Brutsché NE, Ameli R, Furey ML, Zarate CA Jr.

J Psychiatr Res. 2014 Nov;58:161-6. doi: 10.1016/j.jpsychires.2014.07.027. Epub 2014 Aug 12.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk